Literature DB >> 25416605

[Loading and performance capacity after immobilization operations of the spine].

K-D Thomann1, M Rauschmann, S Horn, V Grosser.   

Abstract

BACKGROUND: The results of spondylodesis depend on various medical and non-medical factors. Prerequisites for a good functional result are a well-founded assessment of the indications and a technically successful execution of the intervention. Furthermore, non-medical factors also play an important role. APPRAISAL: Attention must be paid to personal context factors and environmental conditions. In addition to psychological disorders and social background conditions, the economic considerations of the patient and expected pension payments influence the desire and willingness to return to gainful employment. ASESSMENT: Based on the physical findings, the criteria for assessment of the suitability for old-age pension insurance, the reduction in earning capacity for the obligatory social insurance and establishment of the severity of the resulting impairment/handicap according to the Social Compensation Act and the Act for the Severely Handicapped (Social Act IX) in Germany are systematically presented.

Entities:  

Mesh:

Year:  2014        PMID: 25416605     DOI: 10.1007/s00132-014-3048-x

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  10 in total

1.  Criteria for spine fusion with use of H bone graft following disc removal; results in one hundred cases.

Authors:  F E STINCHFIELD; W A SINTON
Journal:  AMA Arch Surg       Date:  1952-10

Review 2.  Fusion versus nonoperative care for chronic low back pain: do psychological factors affect outcomes?

Authors:  Michael D Daubs; Daniel C Norvell; Robert McGuire; Robert Molinari; Jeffrey T Hermsmeyer; Daryl R Fourney; J P Wolinsky; Darrel Brodke
Journal:  Spine (Phila Pa 1976)       Date:  2011-10-01       Impact factor: 3.468

3.  Occupations associated with a high risk of self-reported back pain: representative outcomes of a back pain prevalence study in the Federal Republic of Germany.

Authors:  Sven Schneider; Slawomira Lipinski; Marcus Schiltenwolf
Journal:  Eur Spine J       Date:  2006-01-24       Impact factor: 3.134

4.  [Expert appraisal of spinal injuries].

Authors:  K-D Thomann; V Grosser; M Rauschmann
Journal:  Orthopade       Date:  2010-03       Impact factor: 1.087

5.  [History of the treatment of spinal diseases].

Authors:  P H Feldmann; R H Wittenberg
Journal:  Orthopade       Date:  2001-10       Impact factor: 1.087

6.  Discographic, MRI and psychosocial determinants of low back pain disability and remission: a prospective study in subjects with benign persistent back pain.

Authors:  Eugene J Carragee; Todd F Alamin; Jonothan L Miller; John M Carragee
Journal:  Spine J       Date:  2005 Jan-Feb       Impact factor: 4.166

7.  Leg pain and psychological variables predict outcome 2-3 years after lumbar fusion surgery.

Authors:  Allan D Abbott; Raija Tyni-Lenné; Rune Hedlund
Journal:  Eur Spine J       Date:  2011-02-11       Impact factor: 3.134

8.  [Chronic back pain in the general population in Germany 2002/2003: prevalence and highly affected population groups].

Authors:  H Neuhauser; U Ellert; T Ziese
Journal:  Gesundheitswesen       Date:  2005-10

Review 9.  [Clinical and radiologic legal assessment of spinal injuries using the segmental principle].

Authors:  M Weber; B Wimmer
Journal:  Unfallchirurgie       Date:  1991-08

10.  Psychological factors: anxiety, depression, and somatization symptoms in low back pain patients.

Authors:  Abdulbari Bener; Mohamud Verjee; Elnour E Dafeeah; Omar Falah; Taha Al-Juhaishi; Josia Schlogl; Alhasan Sedeeq; Shehryar Khan
Journal:  J Pain Res       Date:  2013-02-04       Impact factor: 3.133

  10 in total
  1 in total

1.  [ALIF and PLIF interposition in low-grade isthmic spondylolisthesis L5/S1 : Longterm-Comparison of interbody fusion techniques (ALIF - PLIF)].

Authors:  C Fleege; M Arabmotlagh; W Rother; M Rauschmann; M Rickert
Journal:  Orthopade       Date:  2016-09       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.